Bob Langer (left) photographed by Laura Langer; Moderna labs (right) courtesy of Moderna
Topic: Moderna and COVID-19 vaccine development
This special series of the Doing a World of Good Podcast, generously underwritten by Raj and Kamla Gupta, focuses on how chemical engineers and our industry are addressing the coronavirus pandemic.
In this episode, host Bob Knorpp speaks with Dr. Bob Langer, the David H. Koch Institute Professor at MIT, well known bio chemical engineer holding more than 1,300 patents, and member of the board of directors and scientific advisory board at Moderna; and Ray Jordan, head of corporate affairs at Moderna.
Moderna is now one of five companies on President Trump’s short list to be selected to produce a vaccine for the virus. Dr. Langer and Ray Jordan discuss how the company's mission and unique approach to vaccine development using messenger RNA led to their success, their individual contributions to the company, and what's next for Moderna in addressing the COVID-19 crisis including the development of more accurate drug tests, new masks and more.
Listen to AIChE-Doing a World of Good No. 28 with Dr. Bob Langer and Ray Jordan using the audio player below or subscribe below.
The Doing a World of Good podcast is brought to you by Raj & Kamla Gupta. Their support allows the AIChE foundation to continue to share how chemical engineers are Doing a World of Good.